CCN2 and breast carcinoma: During breast cancer progression, TGFβ induces single cell migration through a SMAD-mediated pathway involving downstream activation of epidermal growth factor receptor (EGFR), Jun and Rho signaling pathways, and connective tissue growth factor (CTGF) [83,84].